Abstract
A 38-year-old man with Graves’ disease taking propylthiouracil (PTU) for 6 years developed neutropenia and marked splenomegaly. After subtotal thyroidectomy with discontinuance of PTU the patient remained asymptomatic for the last two and half years. The serum obtained during the period of neutropenia demonstrated opsonic activity to neutrophils of the patient as well as of normal volunteers. This opsonic antineutrophil activity was located in the IgG fraction of the serum. Furthermore, PTU at the concentration (0.1–1.0 μg/ml) attainable in the patient’s serum significantly stimulated [3H] thymidine incorporation in the patient’s lymphocytes. These findings indicate that the patient developed autoimmune neutropenia by producing opsonic antineutrophil antibodies in association with the PTU therapy.
Similar content being viewed by others
References
Cooper D.S. Antithyroid drugs. N. Engl. J. Med. 311: 1353, 1984.
Wing E.S., Asper S.P. Observations on the use of propylthiouracil in hyperthyroidism with especial reference to long term treatment. Bull. Johns Hopkins Hosp. 90: 201, 1952.
Walzer RA, Einbinder J. Immunoleukopenia as an aspect of hypersensitivity to propylthiouracil. JAMA 184:743, 1963.
Best M.M., Duncan C.H. A lupus-like syndrome following propylthiouracil administration. J.Ky. Med. Assoc. 62: 47, 1964.
Faber V., Elling P. Leukocyte-specific anti-nuclear factors in patients with Felty’s syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases. Acta Med. Scand. 179: 257, 1966.
Amrhein J.A., Kenny F.M., Ross D. Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J.Pediatr. 76:54, 1970.
Librik L, Sussman L, Bejar R., Clayton G.W. Thyrotoxicosis and collagen-like disease in three sisters of American indian extraction. J.Pediatr. 76:64, 1970.
Sammon T.J., Peden V.H., Witzleven C., King J.P. Disseminated intravascular coagulation complicating propylthiouracil therapy. A case description of a 16-year old girl. Clin. Pediatr. 70:739, 1971.
Hung W., August G.P. A “collagen-like” syndrome associated with antithyroid therapy. J. Pediatr. 82: 852, 1973.
Vasily D.B., Tyler W.B. Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature. JAMA 243: 458, 1980.
Takuwa N., Kojima I., Ogata E. Lupus-like syndrome — A rare complication in thionam-ide treatment for Graves’ disease. Endocrinol. Jpn. 28: 663, 1981.
Kabashima T. Studies on granulocyte-specific antinuclear factor. Granulocyte-specific antinuclear factor associated with propylthiouracil in patients with hyperthyroidism. Ryumachi 27:22, 1981.
Pacini F., Scridama V., Refetóff S. Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization. J. Endocrinol. Invest. 5: 403, 1982.
Berkman E.M., Orlin J.B., Wolfsdorf J. An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome. Transfusion 23: 135, 1983.
Weinstein A. Drug-induced systemic lupus erythematosus. In: Schwartz R.S. (Ed.), Progress in Clinical Immunology. Grune & Stratton, New York, vol. 4, 1980, p. 1.
DeGroot L.J., Stanbury J.B. The thyroid and its disorders, ed. 4. Jon Willy & Sons, New York, 1975, p. 288.
Boxer L.A., Greenberg M.S., Boxer G.J., Stossel T.P. Autoimmune neutropenia. N Engl. J. Med. 293: 748, 1975.
Weitzman S.A., Stossel T.P., Desmuond M. Drug-induced immunological neutropenia. Lancet?: 1: 1068, 1978.
Boxer LA, Stossel T.P. Effects of anti-human neutrophil antibodies in vitro. quantitative studies. J. Clin. Invest. 53:1534, 1974.
Shishiba Y., Ozawa Y., Ohtsuki N., Shimizu T. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves’ Immunoglob ulin Gs assessed in the mouse. J. Clin. Endocrinol. Metab. 54: 858, 1982.
Waithe W.I., Hirschhom K. Lymphocyte response to activators. In: Weir D.M. (Ed.), Handbook of experimental immunology, ed. 3. Blackwell Publisher, 1978, vol. 2, Chapt. 26:1.
Sato K., Mimura H., Kato S., Isozaki O., Tsushima T., Shizume K. Serum propylthiouracil concentration in patients with Graves’ disease with various clinical course. Acta Endocrinol. 104: 189, 1983.
Woosley R.L., Drayer D.E., Reidenberg M.M., Nies A.S., Carr K., Oates J.A. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N.Engl. J. Med. 298:1157, 1978.
Marchant B., Less J.F.H., Alexander W.D. Antithyroid drugs. Pharmacol. Ther. 3: 305, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sato, K., Miyakawa, M., Han, D.C. et al. Graves’ disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil. J Endocrinol Invest 8, 551–555 (1985). https://doi.org/10.1007/BF03348560
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348560